Insulin dose adjustments with add-on glucagon-like peptide-1 receptor (GLP-1R) agonists in clinical practice
Most clinical trials have focused on people with higher BMIs (27+), but that doesnt mean that these meds wont provide benefits to those who fall below that BMI requirement
Any compounded drugs prescribed are based on a licensed providers medical judgment based on a telehealth encounter and medical history
Regarding the cost of Mounjaro, Its been a roller coaster ride, P.B
With my savings card, I paid a whopping $7,500 for Zepbound in 2024, and my total will be nearly $8,500 in 2025
It was seemingly an interesting biological finding would never have conceived that there was any potential therapeutic benefit for anything, he said